Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: J Pharmacokinet Pharmacodyn. 2012 Aug 30;39(5):577–590. doi: 10.1007/s10928-012-9269-x

Fig. 1.

Fig. 1

Complete model diagram for the common pathway, used for joint analysis of both dulanermin and conatumumab